Landos Biopharma
Blacksburg
About Landos Biopharma
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.The company's therapeutics are novel, locally-acting small molecules targeting inflammatory bowel disease (IBD), crohn's disease (CD) and ulcerative colitis (UC), enabling healthcare providers to cure their patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $70.0M
- Funding stage: M&A
- Last round: Series B (Aug 2019)
- Ticker: nasdaq:LABP
- Website: landosbiopharma.com
- Phone: (540) 218-2232
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/landos-biopharma-1656 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.